Integrated Analysis of Transcriptomic and Genomic Data Reveals Blood Biomarkers With Diagnostic and Prognostic Potential in Non-small Cell Lung Cancer

Background: Lung cancer is the second most common cancer and the main leading cause of cancer-associated death worldwide. Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer diagnoses and more than 50% of all lung cancer cases are diagnosed at an advanced stage; hence have poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaya, Ibrahim H., Al-Harazi, Olfat, Kaya, Mustafa T., Colak, Dilek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930812/
https://www.ncbi.nlm.nih.gov/pubmed/35309509
http://dx.doi.org/10.3389/fmolb.2022.774738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930812/
https://www.ncbi.nlm.nih.gov/pubmed/35309509
http://dx.doi.org/10.3389/fmolb.2022.774738

Ejemplares similares